Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to address supply issues of Ramipril.

All strengths of ramipril capsules and tablets remain available, however, the Department is aware that ramipril 1.25 milligram capsules are in limited supply until early October 2026 due to manufacturing issues affecting some suppliers. We are working closely with suppliers to resolve the disruptions as soon as possible. We have issued comprehensive management guidance to the National Health Service to manage affected patients during this time which includes advice on the use of alternative medicines. We have also issued a Serious Shortage Protocol to limit prescriptions to one month’s supply to support equitable distribution of available stocks.